Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Reports and Findings

Research

The Core Story for Early Childhood Development and Learning in Australia

A core story translates scientific or expert knowledge to make it accessible to the public, practitioners, and policymakers.

Research

Bright Tomorrows Start Today (Parent App)

The Bright Tomorrows app developed at The Kids Research Institute Australia aims to assist parents of children aged 0-5 years to support their child to develop the building blocks of several essential life skills.

Research

Building Out Bullying: The influence of the school environment on bullying behaviour and mental health in primary and secondary school students

The Building Out Bullying project is funded by Healthway and aims to generate policy-relevant evidence, system-level guidelines, and school-based interventions to improve the bullying behaviour and mental health of children attending primary and secondary school in Western Australia.

Research

Amped Up: An Energy Drink Study

Gina Hayley Trapp Christian BHSc(Hons1A), RPHNutr, PhD BSc (1st Class Hons), PhD (Distinction) W.Aust. Honorary Research Associate Head, Child Physical Activity, Health and Development; Ascend Senior Research Fellow 08 6319 1040 Gina.Trapp@

Research

Testing the meningococcal conjugate vaccine MenACWY-TT in toddlers

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle

Research

Study of an oral medication for infants hospitalized with Respiratory Syncytial Virus (RSV) infection

Christopher Jennifer Peter Blyth Kent Richmond MBBS (Hons) DCH FRACP FRCPA PhD RN MBBS MRCP(UK) FRACP Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and

Research

PneumoWA: A case-control study of the role of viral and bacterial pathogens in causing pneumonia among Western Australian children

Christopher Elke Jennifer Peter Tom Blyth Seppanen Kent Richmond Snelling MBBS (Hons) DCH FRACP FRCPA PhD BSc PhD RN MBBS MRCP(UK) FRACP BMBS DTMH GDipClinEpid PhD FRACP Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head,

Research

Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle

Research

Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile Infection

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle

Research

Duration of Pertussis Immunity in Adults: A Study of Health Care Workers

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle